Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Frontiers in Medicine
|
October 29, 2021
Controversials of Microscopic Colitis
Emese Mihaly, Árpád Patai, Zsolt Tulassay
Digestive Diseases (Basel, Switzerland)
|
December 23, 2019
Microscopic Colitis: A Challenging Disorder
Zsolt Tulassay, Emese Mihaly, Lászlo Herszényi
Annals of Internal Medicine
|
August 3, 2005
Regulation of body weight by proopiomelanocortin peptides in humans: lessons from the Nelson syndrome
Rajagopal V Sekhar, J Clay Goodman, Ashok Balasubramanyam, et al.
Diabetes/Metabolism Research and Reviews
|
October 27, 2023
One third of cases of new-onset diabetic ketosis in adults are associated with ketosis-prone type 2 diabetes-A systematic review and meta-analysis
Adrienn Kovacs, Stefania Bunduc, Daniel S Veres, et al.
Journal of Crohn'S & Colitis
|
October 13, 2025
Development and validation of a novel patient-reported outcome for microscopic colitis-Microscopic Colitis Score (MCS)
Katarina Pihl Lesnovska, Samuel Schäfer, Yamile Zabana, et al.
Gastroenterology
|
September 10, 2018
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
Stephan Miehlke, Daniela Aust, Emese Mihaly, et al.
United European Gastroenterology Journal
|
August 20, 2021
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial
Andreas Münch, Emese Mihaly, Ferenc Nagy, et al.
International Journal of Colorectal Disease
|
September 13, 2020
Distribution of histopathological features along the colon in microscopic colitis
Anne-Marie Kanstrup Fiehn, Stephan Miehlke, Daniela Aust, et al.
Lancet (London, England)
|
June 12, 2022
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Bruce E Sands, Peter M Irving, Timothy Hoops, et al.
Journal of Crohn'S & Colitis
|
June 16, 2022
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
Wolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Frontiers in Medicine
|
October 29, 2021
Controversials of Microscopic Colitis
Emese Mihaly, Árpád Patai, Zsolt Tulassay
Digestive Diseases (Basel, Switzerland)
|
December 23, 2019
Microscopic Colitis: A Challenging Disorder
Zsolt Tulassay, Emese Mihaly, Lászlo Herszényi
Annals of Internal Medicine
|
August 3, 2005
Regulation of body weight by proopiomelanocortin peptides in humans: lessons from the Nelson syndrome
Rajagopal V Sekhar, J Clay Goodman, Ashok Balasubramanyam, et al.
Diabetes/Metabolism Research and Reviews
|
October 27, 2023
One third of cases of new-onset diabetic ketosis in adults are associated with ketosis-prone type 2 diabetes-A systematic review and meta-analysis
Adrienn Kovacs, Stefania Bunduc, Daniel S Veres, et al.
Journal of Crohn'S & Colitis
|
October 13, 2025
Development and validation of a novel patient-reported outcome for microscopic colitis-Microscopic Colitis Score (MCS)
Katarina Pihl Lesnovska, Samuel Schäfer, Yamile Zabana, et al.
Gastroenterology
|
September 10, 2018
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
Stephan Miehlke, Daniela Aust, Emese Mihaly, et al.
United European Gastroenterology Journal
|
August 20, 2021
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial
Andreas Münch, Emese Mihaly, Ferenc Nagy, et al.
International Journal of Colorectal Disease
|
September 13, 2020
Distribution of histopathological features along the colon in microscopic colitis
Anne-Marie Kanstrup Fiehn, Stephan Miehlke, Daniela Aust, et al.
Lancet (London, England)
|
June 12, 2022
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Bruce E Sands, Peter M Irving, Timothy Hoops, et al.
Journal of Crohn'S & Colitis
|
June 16, 2022
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
Wolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, et al.
Page
of 2